Veritas offers to know the response to COVID-19 based on the genomics

 

 

 


/COMUNICAE/

Genetic factors are determining to understand the different individual response to the infection, at the margins of age and preconditions. This way it could be explained why certain people do not have just symptoms, while others suffer severe complications.

Veritas Intercontinental launches a new service, COVID-19Risk, which allows you to know the response to COVID-19 infection through genome or exome sequencing with the objective of customizing treatment to avoid medical complications.

 

A sample of saliva is enough to start the process, so it is very easy to access this information through Veritas and its many collaborating centers. On the other hand, those people who already have sequenced their genome with Veritas will be able to get this new update through the service myGenome by Veritas without the need to provide a new sample.

Since the inception of the pandemic, different scientific advances have allowed the identification of genetic factors related to the most serious forms of COVID‐19. These factors are usually related to other pathologies that the patient has but may not have developed completely, and increase the risk of complications if the person has an infection with SARS‐CoV‐2.

The result of this genetic study allows the specialist to anticipate patient management to reduce morbidity and mortality associated with the treatment of COVID‐19. Literatura y libros

The panel COVID-19 Risk, analyzes genes with enough scientific evidence and provides accurate information about different groups of pathologies. The first, identifies those related to increased sensitivity to drugs used to treat the disease. The second group studies the factors that cause reversible metabolic or thrombotic crises. And the third, genetic factors related to diseases that cause cardiopulmonary complications.

According to the doctor Luis Izquierdo, clinical geneticist and Medical Director of Veritas Intercontinentental, genetic factors are determinant to understand the different response observed in patients with a similar starting status by age or preconditions. "This test -indica- is very important because people with pathogenic variants in these genes have a higher risk of complications and this information allows the specialist to customize the treatment in case of COVID-19 infection. For example, carriers of pathogenic variants related to QT-largo syndrome may present heart arrhythmias for the first time after taking medication to treat COVID-19′′.

 

The study COVID-19 Risk for patients who have previously requested myGenome, can be purchased as an isolated service or as part of a new subscription model called Genome Life. This service offers regular updates so that genetic information is always updated in the light of new findings. It also offers Veritas patients the possibility of having additional genetic counselling, a direct line with their medical experts, and the possibility, in short, of always having updated genetic information for the best health care.

Veritas offers to know the response to COVID-19 based on the genomics

Veritas offers to know the response to COVID-19 based on the genomics

Genetic factors are determining to understand the different individual response to the infection, at the margins of age and preconditions. This way it could be

nails

en

https://doityour.health/static/images/nails-veritas-offers-to-know-the-response-to-covid-19-based-on-the-genomics-1258-0.jpg

2024-05-20

 

Veritas offers to know the response to COVID-19 based on the genomics
Veritas offers to know the response to COVID-19 based on the genomics

Acording with the Digital Millennium Copyright Act (“DMCA”), Pub. L. 105-304 If you believe that your copyrighted work is being infringed, notify our team at the email [email protected]

 

 

Update cookies preferences